| SUNDAY |
| 2:00 pm - 9:00 pm | Arrival and check-in |
| 6:00 pm | Dinner |
| 7:30 pm - 9:30 pm | A HISTORICAL APPROACH TO THE EPIDEMIOLOGY OF MALARIA |
| Discussion Leader: David Bradley |
| David Bradley
Have we been here before, and what should we have learned? |
| Louis Molineaux
The Garki Project: genesis of the project, selected results |
| Mark Honigsbaum
The Fever Bark Tree: the bitter-sweet legacy of the world's
first antimalarial |
| Jeffrey Sachs
The future of malaria control and its economic basis |
| MONDAY |
| 7:45 am - 8:30 am | Breakfast |
| 9:00 am - 12:30 pm | SURVEILLANCE FOR MALARIA |
| Discussion Leader: Don de Savigny |
| Erin Eckert
Monitoring malaria programs: the role of population surveys |
| Don de Savigny
Prospective surveillance for malaria:
emerging opportunities for a sentinel approach |
| Coffee Break |
| Eline Korenromp
Trends in childhood malaria mortality in Africa: assessments based on verbal autopsy in longitudinal surveillance systems |
| David Rogers
Geographical information systems |
| 12:45 pm | Lunch / Photo |
| 1:30 pm - 4:00 pm | Free Time |
| 4:00 pm - 6:00 pm | Poster Session I |
| 6:00 pm | Dinner |
| 7:30 pm - 9:30 pm | MODELLING OF MALARIA |
| Discussion Leader: Klaus Dietz |
| Klaus Dietz
General model |
| Ellis McKenzie
A brief overview of malaria modelling |
| Tarekegn Abeku
Modelling the effects of reducing transmission on malaria-related mortality |
| Ian Hastings
Drug resistance |
| TUESDAY |
| 7:45 am - 8:30 am | Breakfast |
| 9:00 am - 12:30 pm | CHANGING PATTERNS OF MALARIA |
| Discussion Leader: Joel Breman |
| Joel Breman
All-cause mortality and malaria in African children: trends and controversies |
| Richard Allan
Complex emergencies - new approaches to malaria control
in extreme settings |
| Coffee Break |
| Rick Steketee (presented on behalf of Peter Bloland)
Drug resistance and malaria mortality |
| Clifford Mutero
Malaria and agriculture: the links and the challenges |
| 12:30 pm | Lunch |
| 1:30 pm - 4:00 pm | Free Time |
| 4:00 pm - 6:00 pm | Poster Session II |
| 6:00 pm | Dinner |
| 7:30 pm - 9:30 pm | MALARIA AND HIV |
| Discussion Leader: Rick Steketee / Bernard Nahlen |
| Rick Steketee
Pregnancy |
| Eleanor Riley
The immunological basis for potential interactions between
HIV and malaria |
| Jimmy Whitworth
The epidemiological evidence of an effect of HIV on malaria |
| James Kublin
The impact of malaria on HIV in a cohort of
Malawian adults |
| Feiko ter Kuile
Malaria and HIV in pregnancy and effects on the infant |
| WEDNESDAY |
| 7:45 am - 8:30 am | Breakfast |
| 9:00 am - 12:30 pm | THE EPIDEMIOLOGY OF CLINICAL MALARIA |
| Discussion Leader: Kevin Marsh |
| Jane Crawley
Anaemia |
| Charles Newton
The effect of Plasmodium falciparum on the brain |
| Coffee Break |
| Bernard Nahlen
Epidemiology and control of malaria during pregnancy |
| Hans Verhoef
Malaria and nutrition |
| 12:30 pm | Lunch |
| 1:30 pm - 4:00 pm | Free Time |
| 4:00 pm - 6:00 pm | Poster Session III |
| 6:00 pm | Dinner |
| 7:00 pm | Business Meeting |
| 7:30 pm - 9:30 pm | THE EPIDEMIOLOGY OF DRUG RESISTANCE |
| Discussion Leader: Anders Björkman |
| Anders Björkman
Drug resistant malaria - implications and research challenges |
| Nick White
Preventing antimalarial drug resistance |
| Abdoulaye Djimde
Molecular methods and the epidemiological surveillance of antimalarial drug resistance |
| Catherine Goodman
Implementing combination therapy - the challenge of the African retail sector |
| THURSDAY |
| 7:45 am - 8:30 am | Breakfast |
| 9:00 am - 12:30 pm | EPIDEMIOLOGY AND VECTOR CONTROL |
| Discussion Leader: Chris Curtis |
| Brian Sharpe
Vector Control |
| Bill Hawley
GIS |
| Coffee Break |
| Frank Collins
Genetics |
| Christophe Boëte
Genetics |
| 12:30 pm | Lunch |
| 1:30 pm - 4:00 pm | Free Time |
| 4:00 pm - 6:00 pm | Poster Session IV |
| 6:00 pm | Dinner |
| 7:30 pm - 9:30 pm | EVALUATION OF MALARIA VACCINE |
| Discussion Leader: Pedro Alonso |
| Allan Saul
(phase 1 / 2 studies)
Clinical development plan for transmission blocking vaccines: minimum
efficacy for a deployable vaccine and feasibility of testing through
Phase 1, Phase 2 and Phase 3 trials |
| Kalifa Bojang
Evaluation of malaria vaccine: Phase 111 trials |
| Tom Smith
What should we measure in malaria vaccine trials? |
| FRIDAY |
| 7:45 am - 8:30 am | Breakfast |
| 9:00 am | Departure |
